
Keywords: Loperamide; Opioid receptor; Pain; Nav1.7; Sodium channel; MOR; mu-opioid receptor; VGSCs; Voltage-gated sodium channels; HEK; human embryo kidney; KO; knock-out; PWF; paw withdrawal frequency; CFA; complete Freund's adjuvant; DRG; dorsal root ganglion; P